HER2 (ERBB2) Mutations in NSCLC: Mechanism of Disease

<p><em>HER2 (ERBB2)</em> mutations may increase receptor internalization and lead to hyperactive downstream signaling, uncontrolled cell growth, and tumorigenesis. Learn more about how <em>HER2</em> mutations affect several types of cancer, including non-small cell lung cancer (NSCLC).</p> <p>Intended for US Healthcare Professions only </p> <p style="text-align: right;">©2022 Daiichi Sankyo, Inc. and AstraZeneca. PP-US-8201a-1332 06/22</p>